J&J Vaccine Producer Grilled at House Hearing on Botched Vaccine Doses, Lavish Executive Bonuses, Stock Sales

A House panel investigation revealed taxpayers paid Johnson & Johnson vaccine manufacturer, Emergent Biosolutions, $271 million under vaccine contracts despite “serious deficiencies” at the Baltimore plant.